SMAD4 and colitis: These findings offer conceptually novel insights into the development and pathogenesis of IBD and CAC by revealing the role of the TGF‐β/Smad4 disruption in shaping the immune response, which have therapeutic implications on IBD and colitis‐associated tumorigenesis.